LaserSight first to offer integrated corneal topography PRK laser.ORLANDO, Fla.--(BUSINESS WIRE)--Nov. 2, 1994--LaserSight Incorporated (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :LASE) has conducted successful pre-clinical testing of the unique PAR corneal topography machine in conjunction with Photorefractive Keratectomy Photorefractive keratectomy (PRK) A procedure that uses an excimer laser to make modifications to the cornea and permanently correct myopia. Mentioned in: Myopia, Radial Keratotomy photorefractive keratectomy (PRK PRK photorefractive keratectomy. Photorefractive keratectomy (PRK) A procedure that uses an excimer laser to make modifications to the cornea and permanently correct myopia. ) using the LaserSight Compaq-200 Mini-Excimer. PAR is a product of PAR Vision Systems, Inc. New Hartford, NY. The PAR system can be readily mounted onto LaserSight's Mini-Excimer and can use the same computer platform. The PAR system confirms the centration, smoothness, and accuracy of the ablation; and for the first time, PRK affects on the cornea cornea: see eye. can be directly measured at the time of treatment. LaserSight is the first company to offer a corneal topography analyzer integrated with a PRK laser. The PAR system, coupled with LaserSight's Automated PRK System, is an innovation in PRK technology. The Mini-Excimer with the topographic and Automated Excimer PRK Scystem is being demonstrated at the American Academy of Ophthalmology The American Academy of Ophthalmology (AAO) is a medical association of ophthalmologists–medical doctors (MDs) specializing in eye care and surgery). The group is based in San Francisco, California. meeting in San Francisco through November 3rd. CONTACT: LaserSight Inc.
Robert Qualls, Chief Executive Officer
803/768-3505
or
Gregory L. Wilson, Chief Financial Officer
314/576-1563
or
Marti Benfield, Investor Relations
314/576-1563
|
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion